Surgical Site Infection
SSI is an infection occurring within 30 days of surgery (or 1 year if an implant is placed). It is the most common healthcare-associated infection in surgical patients, affecting 3-5% of operations.
Key Facts
Most common healthcare-associated infection in surgical patients; affects ~3-5% of all surgical procedures Classification: Superficial incisional (skin/subcutaneous), deep incisional (fascia/muscle), organ/space (e.g., intra-abdominal abscess) Most common organisms: Staphylococcus aureus (most common overall), coagulase-negative staphylococci (implants), E. coli (abdominal surgery) Risk factors: Contaminated/dirty surgery, obesity, diabetes, smoking, immunosuppression, ASA grade ≥3, prolonged surgery, emergency surgery Wound classification: Clean (1-2% SSI), clean-contaminated (3-5%), contaminated (5-10%), dirty (10-40%) Prophylactic antibiotics: Single dose at induction for clean-contaminated and contaminated surgery; not routinely for clean surgery unless implant NICE NG125: SSI prevention and treatment guidelines MRSA screening: Pre-operative screening and decolonisation (mupirocin nasal ointment + chlorhexidine body wash) reduces SSI
Overview
Key Facts
SSI is a significant cause of post-operative morbidity, prolonged hospital stay, increased cost, and mortality. Prevention through best practice ('care bundles') is more effective than treatment.
Epidemiology
~3-5% of all surgical procedures; higher in emergency surgery (~10%). Accounts for ~16% of all healthcare-associated infections in UK. Increases hospital stay by ~7-10 days. Estimated cost: ~£10,000 per SSI episode.
Aetiology
Patient factors: Obesity, diabetes, smoking, malnutrition, immunosuppression, extremes of age, chronic disease Surgical factors: Wound classification, surgical duration, technique, emergency surgery, foreign body/implant, drains, hypothermia, hyperglycaemia Microbial factors: MRSA carriage, pre-existing infection, wound contamination
Pathophysiology
- Bacterial contamination of surgical wound → exceeds host defence capacity → infection
-
10⁵ organisms per gram of tissue generally required for infection (lower threshold with foreign body/implant)
- Biofilm formation on implants → chronic infection resistant to antibiotics
Clinical Presentation
Superficial SSI (Most Common)
- Within 30 days of surgery
- Involves skin and subcutaneous tissue only
- Erythema, warmth, swelling, tenderness around wound
- Purulent discharge
- Wound dehiscence may occur
Deep SSI
- Involves fascia and/or muscle layers
- May present with deep wound abscess
- Fever, pain, systemic sepsis possible
Organ/Space SSI
- Infection in any part of the body opened/manipulated during surgery (excluding the incision)
- e.g., Intra-abdominal abscess after laparotomy, empyema after thoracotomy
- May present days-weeks post-operatively with fever, pain, or sepsis
Red Flags
- Systemic sepsis (fever, tachycardia, hypotension) with wound signs
- Rapidly spreading wound infection — consider necrotising fasciitis
- Prosthetic joint infection — orthopaedic emergency
- Sternal wound infection post-cardiac surgery — high mortality
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Normal post-operative inflammation | Mild warmth/redness in first 48-72 hours, improving | Clinical |
| Wound haematoma | Swelling, bruising, no pus or fever | US |
| Seroma | Fluctuant collection, clear fluid, no infection signs | US, aspiration |
| Allergic reaction to dressing | Erythema matching dressing pattern, itching | Clinical |
| Necrotising fasciitis | Rapidly spreading, severe pain, systemic toxicity | Clinical — emergency surgery |
Diagnosis / Investigation
Bedside
- Wound assessment: Signs of infection (rubor, calor, tumor, dolor, pus)
- Wound swab: If purulent discharge — send for MC&S (not routine for surveillance)
- Observations: NEWS2
Bloods
- FBC, CRP: Raised WCC and CRP
- Blood cultures: If systemic sepsis
- Procalcitonin: May help guide antibiotic duration
Imaging
- USS: Wound collection/abscess
- CT: Deep/organ-space SSI (e.g., intra-abdominal abscess)
- MRI: Prosthetic joint infection, osteomyelitis
Management
Prevention (NICE NG125 — SSI Care Bundle)
- Pre-operative: MRSA screening and decolonisation, smoking cessation, glucose optimisation, nutritional optimisation, hair removal with clippers (not razor), skin preparation (2% chlorhexidine in 70% isopropyl alcohol)
- Intraoperative: Prophylactic antibiotics at induction (within 60 minutes before incision), maintain normothermia (>36°C), meticulous surgical technique, minimise tissue handling
- Post-operative: Sterile dressing for 48 hours, hand hygiene, appropriate wound care
Prophylactic Antibiotics
- Clean surgery without implant: Not routinely indicated
- Clean with implant: Single dose at induction (e.g., cefazolin 2g IV)
- Clean-contaminated: Single dose at induction (e.g., co-amoxiclav 1.2g IV)
- Contaminated/dirty: Therapeutic course of antibiotics (not just prophylaxis)
Treatment of Established SSI
- Superficial: Open wound, drain pus, irrigate; may not need systemic antibiotics if localised
- Deep/organ-space: IV antibiotics (guided by cultures); drainage of collections (percutaneous or surgical)
- Implant-related infection: Often requires implant removal, debridement, prolonged antibiotics
- MRSA SSI: Vancomycin 15-20mg/kg IV BD or linezolid 600mg IV/PO BD
Referral Criteria
- Deep/organ-space SSI — surgical team
- Prosthetic joint infection — orthopaedic specialist
- MRSA infection — microbiology advice
Prognosis
- Superficial SSI: Usually resolves with local wound care; minimal morbidity
- Deep/organ-space SSI: Significant morbidity; may require reoperation; mortality ~5-10% in severe cases
- Prosthetic joint infection: Complex; may require implant removal; long-term functional impact
- Increased hospital stay: ~7-10 days per SSI episode
- Financial cost: ~£10,000 per SSI episode
- Prevention: Care bundles reduce SSI rates by 30-50%
Other Relevant Information
Wound Classification (CDC)
| Class | Definition | SSI Rate | Example |
|---|---|---|---|
| Clean | No entry to hollow viscus, no inflammation | 1-2% | Hernia repair, thyroidectomy |
| Clean-contaminated | Controlled entry to hollow viscus | 3-5% | Cholecystectomy, appendicectomy |
| Contaminated | Spillage from viscus, fresh traumatic wound | 5-10% | Penetrating trauma, gross spillage |
| Dirty | Established infection, perforated viscus | 10-40% | Perforated appendicitis, abscess drainage |